NCT05983315

Brief Summary

Colorectal neoplastic lesion endoscopic characterization is a key element for histological predictive diagnostic value in conducting best appropriate resection choice. Six classifications are necessary for fully correct characterization of different colorectal lesions. Nonetheless, it can be tricky to use so many diagnostic tools with so many subcategories in the 6 existing classifications. That's why we decided to integrate all 6 existing classification validated factors in one single chart (CONECCT chart) allowing to both predict histological diagnostic value and to propose the best appropriate resection strategy. A previous prospective and multicentre study with all French medical residents in gastroenterology was conducted in order to prove pedagogic interest of this diagnostic tool. Each student was asked to review 20 files with lesion pictures before and after lecture about CONECCT chart. This allowed us to prove that this diagnostic tool could significantly improve both histological predictive diagnostic value and therapeutic choice by French medical residents and gastroenterologists. Our hypothesis is that CONECCT's classification can improve predictive diagnostic value of colorectal lesions in over 80% of cases. Now that pedagogic interest of this diagnostic tool has been proven, we would like to carry out a larger prospective assessment in term of performance (value) of this instrument in order to both facilitate endoscopic characterization and allow a most appropriate diagnostic and therapeutic management of each colorectal lesion category.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
750

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2022

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 1, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 9, 2023

Completed
Last Updated

August 9, 2023

Status Verified

August 1, 2023

Enrollment Period

1 year

First QC Date

August 1, 2023

Last Update Submit

August 1, 2023

Conditions

Keywords

diagnostic toolcolorectal cancertherapeutic choice guidanceCONECCT

Outcome Measures

Primary Outcomes (1)

  • Correlation between endoscopic CONECCT's classification

    assessed by one of research site operators and final histology reading of neoplastic lesion by anatomopathologist: * CONECCT 0E : neuroendocrine tumor * CONECCT IH : hyperplastic polyp * CONECCT IS : sessile serrated lesion with or without dysplasia * CONECCT IIA : low or high grade adenoma * CONECCT IIC : low or high grade adenoma or intramucosal or submucosal \<1000 micron adenocarcinoma * CONECCT III : deep invasive submucosal \> 1000 microns adenocarcinoma

    Time point can be reached either 2 weeks after endoscopic resection at V1 or between 2-4 months later in case of surgery at V3

Study Arms (1)

CONECCT's classification assessment

Every patient who needs diagnostic colonoscopy because of digestive symptoms, medical or family history of colorectal cancer/polyps, positive colorectal screening test, acromegaly or referred by another gastroenterologist upon discovery of colorectal polyp after colonoscopy can join the cohort of this study and can get CONECCT's classification histological assessment of their neoplastic lesion by experienced endoscopist.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Every patient who needs diagnostic colonoscopy because of digestive symptoms, medical or family history of colorectal cancer/polyps, positive colorectal screening test, acromegaly or referred by another gastroenterologist upon discovery of colorectal polyp after colonoscopy can join the cohort of this study.

You may qualify if:

  • both gender patients even or older than 18 years old
  • patient in need of proven diagnostic or therapeutic colonoscopy for colorectal lesion resection
  • patient with French Health Insurance coverage
  • obtaining of oral non opposition to research after loyal, clear and complete delivery of information

You may not qualify if:

  • previous attempt of lesion resection by mucosectomy
  • patient with a metastatic lesion diagnosed prior to colonoscopy
  • patient with no colorectal lesion
  • adenomatous or sessile serrated polyposis syndrome
  • patient with bowel chronic inflammatory disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Edouard Herriot

Lyon, 69437, France

Location

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2023

First Posted

August 9, 2023

Study Start

July 1, 2021

Primary Completion

July 1, 2022

Study Completion

November 1, 2022

Last Updated

August 9, 2023

Record last verified: 2023-08

Locations